Leslie Sharp is the founder of OncoMyx Therapeutics. OncoMyx Therapeutics has raised $75M in total funding. Latest round: Series B. Based in Phoenix, AZ.
Leslie Sharp is the Chief Scientific Officer of OncoMyx Therapeutics, a spinout from Arizona State University. The company is developing anti-cancer therapies using a rabbit pox virus called myxoma, which is armed with transgenes to suppress various types of cancer. Preclinical data show the virus can slow tumor growth and is effective when combined with PD-1 or PD-L1 inhibitors.
Full founder directory · Investor directory · Company funding database · Fundraising library